PIONEER research associates from both academic and industry discuss their experience of working together

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project

Denis Horgan explains the importance of actively engaging policy makers in PIONEER

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Controversies in the management of prostate cancer

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months